Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
RXST
RXST
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RXST News
RxSight, Inc. Reports Q4 2025 Earnings with Strategic Insights
Feb 26 2026
seekingalpha
RxSight Issues 2026 Financial Guidance with Q4 Results
Feb 25 2026
seekingalpha
U.S. Stocks Mixed; Day One Biopharmaceuticals Shares Surge 20%
Jan 12 2026
Benzinga
Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%
Jan 12 2026
Benzinga
RxSight Expects Q4 2025 Revenue of $32.6 Million, Appoints CFO
Jan 11 2026
NASDAQ.COM
RxSight Reports $134.5M Revenue for 2025, Announces CFO Transition
Jan 11 2026
Globenewswire
RxSight to Present at J.P. Morgan Healthcare Conference on January 13, 2026
Jan 02 2026
Globenewswire
RxSight to Present at J.P. Morgan Healthcare Conference on January 13, 2026
Jan 02 2026
Newsfilter
RxSight Faces Securities Fraud Investigation Following CFO Departure
Jan 01 2026
PRnewswire
RxSight CFO Shelley Thunen Transitions to Consultant Role Until 2026
Dec 23 2025
NASDAQ.COM
RxSight CFO Shelley Thunen Transitions, Supporting Company Growth
Dec 22 2025
Globenewswire
Ross Stores Reports Impressive Q3 Earnings, Alongside Enviri, Azenta, and Other Major Stocks Rising on Friday
Nov 21 2025
Benzinga
Needham Keeps Buy Rating on RxSight and Increases Price Target to $12
Nov 06 2025
Benzinga
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead
Nov 06 2025
NASDAQ.COM
RXSIGHT UPDATE: Bragar Eagel & Squire, P.C. Investigates RxSight, Inc. for Long-Term Shareholders and Urges Investors to Reach Out to the Firm
Oct 08 2025
Globenewswire
RxSight, Inc. Shareholders Urged to Reach Out to Levi & Korsinsky by September 22, 2025 to Explore Their Rights – RXST
Sep 22 2025
Globenewswire
Show More News
